As the innovative, multi-billion dollar industry expands rapidly, pharma companies must consider how to deliver and differentiate.AstraZeneca’s recent $2 billion acquisition of a radiopharmaceutical partner was the latest sign that the market for these new therapies is growing quickly — and that the competition among pharma giants for dominance in the space is heating up. […]
